EU/UK Qualified Person (QP) Services and MIA license
Products
Information
Navigating both general and country-specific regulations and requirements to supply medicinal products to the European markets can be a complex challenge for Marketing Authorization Holders (MAH). ProPharma holds both EU and UK MIA licenses which allows us to help clients overcome the complexities of supplying to the EU and UK markets, such as creating tailored strategies to navigate country-specific and national regulations. MAHs can utilize ProPharma's MIA license and QP in the region to ensure products are released to patients in need a cross the EU and UK in a quick and flexible way. It can take more than 1 year to obtain their own MIA license, but MAHs can greatly accelerate their timelines to get products listed within 3-4 months utilizing ProPharma's licenses.
Distribution Areas
OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)
All categories
Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)Consulting ServicesLogistics and DistributionClinical Trials Phase I to IVProject ManagementBiopharmaceutical ServicesContract Research Organisations (CROs)AuditServices
Main Categories
Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)Biopharmaceutical ServicesContract Research Organisations (CROs)
